These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 27086572)

  • 1. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.
    Zhang C; Sun A; Zhang P; Wu C; Zhang S; Fu M; Wang K; Zou Y; Ge J
    Diabetes Res Clin Pract; 2010 Feb; 87(2):211-8. PubMed ID: 19853947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and Risks Associated With Aspirin Use in Patients With Diabetes for the Primary Prevention of Cardiovascular Events and Mortality: A Meta-Analysis.
    Ma H; Gu Q; Niu H; Li X; Wang R
    Front Endocrinol (Lausanne); 2021; 12():741374. PubMed ID: 34539583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials.
    Seidu S; Kunutsor SK; Sesso HD; Gaziano JM; Buring JE; Roncaglioni MC; Khunti K
    Cardiovasc Diabetol; 2019 Jun; 18(1):70. PubMed ID: 31159806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
    Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
    Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
    Wolff T; Miller T; Ko S
    Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for the prevention of cardiovascular morbidity.
    Sanchez-Ross M; Waller AH; Maher J; Klapholz M; Haider B; Kaluski E
    Minerva Med; 2010 Aug; 101(4):205-14. PubMed ID: 21030934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G; Postula M; Pecen L; Halvorsen S; Lesiak M; Schoergenhofer C; Jilma B; Hengstenberg C; Siller-Matula JM
    BMC Med; 2019 Nov; 17(1):198. PubMed ID: 31679516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin for primary prevention of cardiovascular outcomes in diabetes mellitus: An updated systematic review and meta-analysis.
    Khan SU; Ul Abideen Asad Z; Khan MU; Talluri S; Ali F; Shahzeb Khan M; Lone AN; Mookadam F; Krasuski RA; Kaluski E
    Eur J Prev Cardiol; 2020 Dec; 27(19):2034-2041. PubMed ID: 30700151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.
    Calvin AD; Aggarwal NR; Murad MH; Shi Q; Elamin MB; Geske JB; Fernandez-Balsells MM; Albuquerque FN; Lampropulos JF; Erwin PJ; Smith SA; Montori VM
    Diabetes Care; 2009 Dec; 32(12):2300-6. PubMed ID: 19741185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
    Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
    J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Meta-Analysis of Aspirin for the Primary Prevention of Cardiovascular Diseases in the Context of Contemporary Preventive Strategies.
    Shah R; Khan B; Latham SB; Khan SA; Rao SV
    Am J Med; 2019 Nov; 132(11):1295-1304.e3. PubMed ID: 31153866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
    Butalia S; Leung AA; Ghali WA; Rabi DM
    Cardiovasc Diabetol; 2011 Apr; 10():25. PubMed ID: 21453547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aspirin on mortality in the primary prevention of cardiovascular disease.
    Raju N; Sobieraj-Teague M; Hirsh J; O'Donnell M; Eikelboom J
    Am J Med; 2011 Jul; 124(7):621-9. PubMed ID: 21592450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.